Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/fluticasone inhalation vs Seretide in asthma
CTR20213451Phase 3Completed
- Sponsor
- Sichuan Puruite Pharmaceutical Technology
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by Sichuan Puruite Pharmaceutical Technology. Started Jan 2022; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20213451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213451.